US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Diagnostics Company Reports Market Research Reports & Industry Analysis

RSS Feeds

Diagnostics Company Reports Industry Research & Market Reports

  2    4  5  6  7  8  9  10  
Bracco S.p.A. - Strategic SWOT Analysis Review
6/28/2016 | published by: GlobalData
... employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope Business ...  |  read more...
USD 125
Myriad RBM (formerly Rules-Based Medicine, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
6/30/2016 | published by: MarketLine
... of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. This report includes Myriad RBM (formerly Rules-Based Medicine, Inc.)'s contact information and business summary, tables, graphs, a list of ...  |  read more...
USD 350
QIAGEN N.V. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
6/30/2016 | published by: MarketLine
... inorganic growth activity undertaken by an organization to sustain its competitive advantage. This report includes QIAGEN N.V.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and ...  |  read more...
USD 350
Pacific Biosciences of California, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
6/30/2016 | published by: MarketLine
... the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. This report includes Pacific Biosciences of California, Inc.'s contact information and business summary, tables, graphs, a list of partners and ...  |  read more...
USD 350
Nanosphere, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
6/30/2016 | published by: MarketLine
... inorganic growth activity undertaken by an organization to sustain its competitive advantage. This report includes Nanosphere, Inc.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and ...  |  read more...
USD 350
Siemens Healthcare Diagnostics, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
6/30/2016 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. This report includes Siemens Healthcare Diagnostics, Inc.'s contact information and business summary, tables, graphs, a list of partners and targets, a ...  |  read more...
USD 350
Gen-Probe Incorporated – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
6/30/2016 | published by: MarketLine
... inorganic growth activity undertaken by an organization to sustain its competitive advantage. This report includes Gen-Probe Incorporated's contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and ...  |  read more...
USD 350
Epigenomics AG – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
6/30/2016 | published by: MarketLine
... inorganic growth activity undertaken by an organization to sustain its competitive advantage. This report includes Epigenomics AG's contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and ...  |  read more...
USD 350
Quest Diagnostics Incorporated – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
6/30/2016 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. This report includes Quest Diagnostics Incorporated's contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of ...  |  read more...
USD 350
Alliance Healthcare Services, Inc. (AIQ) - Financial and Strategic SWOT Analysis Review
6/1/2016 | published by: GlobalData
... bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you ...  |  read more...
USD 125
Biotest AG (BIO) - Financial and Strategic SWOT Analysis Review
6/7/2016 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Epigenomics AG (ECX) - Financial and Strategic SWOT Analysis Review
6/1/2016 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Exact Sciences Corporation (EXAS) - Financial and Strategic SWOT Analysis Review
6/1/2016 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
GeneFluidics Inc. - Product Pipeline Analysis, 2016 Update
5/25/2016 | published by: GlobalData
... robotic automation system, point of care system and systems operation cartridges, among others. GeneFluidics’ molecular analysis platform enables bioassays to perform immunoassays and genetic assays, without the use of purification. The company offers testing system ...  |  read more...
USD 750
Shimadzu Corporation (7701) - Financial and Strategic SWOT Analysis Review
6/1/2016 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
TrovaGene, Inc. (TROV) - Product Pipeline Analysis, 2016 Update
5/25/2016 | published by: GlobalData
... tests are used in detection of transrenal DNA (TrDNA) and RNA (TrRNA). The technology is used in tumor detection and monitoring, prenatal genetic testing, infectious diseases, tissue transplantation, forensic identification, and for patient selection in ...  |  read more...
USD 750
Accelerate Diagnostics, Inc. (AXDX) - Financial and Strategic SWOT Analysis Review
6/1/2016 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
Cellavision AB (CEVI) - Financial and Strategic SWOT Analysis Review
5/24/2016 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
TrovaGene, Inc. (TROV) - Financial and Strategic SWOT Analysis Review
5/24/2016 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Venaxis, Inc. (APPY) - Financial and Strategic SWOT Analysis Review
6/1/2016 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Medical Diagnostics, Reagents, Assays and Test Kits Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2022, NAIC 325413
5/5/2016 | published by: Plunkett Research, Ltd.
... that will save countless hours of research. Key Findings: Medical Diagnostics, Reagents, Assays and Test Kits Manufacturing Industry (U.S.) to reach $23.3 billion by 2022. Medical Diagnostics, Reagents, Assays and Test Kits Manufacturing Industry, including ...  |  read more...
USD 1,995
2016-2020 World In Vitro Diagnostic Instrumentation Review
5/6/2016 | published by: VPGMarketResearch.com
... segments: - Blood Typing, Grouping, and Screening - Cancer Diagnostic - Clinical Chemistry and Immunodiagnostics - Coagulation Testing - Hematology and Flow Cytometry - Microbiology - Molecular Diagnostics Contains 170 pages Please note: The delivery ...  |  read more...
USD 6,500
Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2010-2016
5/1/2016 | published by: Current Partnering
... to the collaborative R&D deals and agreements entered into by the worlds leading life science companies. This report provides details of the latest collaborative R&D deals announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully ...  |  read more...
USD 2,995
Global Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2016
5/1/2016 | published by: Current Partnering
... to the royalty financing agreements entered into by the worlds leading biopharma companies. The report provides a detailed understanding and analysis of how and why companies enter business, royalty financing agreements. The focus of the ...  |  read more...
USD 1,995
Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2016
5/1/2016 | published by: Current Partnering
... of the latest manufacturing and supply agreements announced in the pharmaceutical, biotechnology, device and diagnostic sectors. Fully revised and updated, the report provides details of manufacturing and supply agreements from 2010 to 2016. The report ...  |  read more...
USD 2,995
  2    4  5  6  7  8  9  10